Luteal Phase Support
3
0
0
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
6 treatments under study, led by Progesterone
Related Conditions
Often studied with 4 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 3 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (3)
An Open Labeled RCT on the Effect of Additional hCG Injection for LPS on Pregnancy Outcomes in IHH Patients
Two Different Types of Luteal Phase Support in Natural Cycle Frozen Embryo Transfer and Its Effect on Pregnancy Rates
Patient's Preferences About Subcutaneous or Vaginal Progesterone Administration for Luteal Phase Support
Research Network
Common Treatments
- Progesterone1
- Hcg1
- Gnrh Agonist1
- Progesterone 100mg Vag Tab1
- Additional Hcg Injection1
Active Sponsors
- Shaare Zedek Medical Center1
- Fudan University1
- Universita di Verona1
Top Investigators
Universita di Verona
Universita di Verona
AOUI Verona
Università degli Studi dell'Insubria
Sharee Zedek Medical Center, Israel
Related Conditions
- Idiopathic Hypogonadotropic Hypogonadism1
- Luteal Phase Deficiency1
- Progesterone1
- In Vitro Fertilization1